Showing results (11-20 of 572) with videos related to
Sort By:
Pageof 58
Cancer Metastasis Reviews|April 19, 2013
Personalized radiation therapy and biomarker-driven treatment strategies: a systematic reviewJean-Emmanuel Bibault, Ingrid Fumagalli, Charles Ferté, et al.Cancer Metastasis Reviews|September 13, 2008
Molecular profiling of uterine cervix carcinoma: an overview with a special focus on rationally designed target-based anticancer agentsNicolas Magné, Cyrus Chargari, Eric Deutsch, et al.Seminars in Radiation Oncology|November 16, 2019
Radiobiology: Foundation and New Insights in Modeling Brachytherapy EffectsPierre Annede, Jean-Marc Cosset, Erik Van Limbergen, et al.Cancer Treatment Reviews|March 18, 2016
Optimize and refine therapeutic index in radiation therapy: Overview of a centuryCyrus Chargari, Nicolas Magne, Jean-Baptiste Guy, et al.Presse Medicale (Paris, France : 1983)|August 27, 2013
Complications of chemotherapy, a basic science updateMarianne Mazevet, Maryline Moulin, Anna Llach-Martinez, et al.Cancer Letters|March 19, 2016
Nanoparticles in radiation oncology: From bench-side to bedsideChloé Rancoule, Nicolas Magné, Alexis Vallard, et al.European Journal of Cancer (Oxford, England : 1990)|July 2, 2022
Practice changing data and emerging concepts from recent radiation therapy randomised clinical trialsSophie Espenel, Cyrus Chargari, Pierre Blanchard, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2020
Methodological Development of Combination Drug and Radiotherapy in Basic and Clinical ResearchCyrus Chargari, Antonin Levy, Xavier Paoletti, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 28, 2016
Leukocytosis and neutrophilia predicts outcome in anal cancerAntoine Schernberg, Alexandre Escande, Eleonor Rivin Del Campo, et al.Cancer Letters|September 23, 2011
Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenograftsCyrus Chargari, Celine Leteur, Eric Angevin, et al.Pageof 58